Hebei Changshan Biochemical Pharmaceutical announced that the company's pharmaceutical Enoxaparin Sodium Injection obtained a drug registration certificate issued by the Nigerian National Agency for Food and Drug Administration and Control. The drug is named Enoxaparin Sodium Injection, with the dosage form being an injection, the specification is 0.6ml, and the expiration date is September 11, 2028. Enoxaparin Sodium Injection is mainly used for the prevention of venous thromboembolic diseases and the treatment of deep vein thrombosis.
常山药业：依诺肝素钠注射液获尼日尔药品注册证书
Hebei Changshan Biochemical Pharmaceutical: Enoxaparin Sodium Injection obtained the pharmaceutical registration certificate in Niger.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated